TGF-β3 mediates mitochondrial dynamics through the p-Smad3/AMPK pathway

Abstract

It is well recognized that mitochondrial dynamics plays a vital role in cartilage physiology. Any perturbation in mitochondrial dynamics could cause disorders in cartilage metabolism and even lead to the occurrence of cartilage diseases such as osteoarthritis (OA). TGF-β3, as an important growth factor that appears in the joints of OA disease, shows its great potential in chondrocyte growth and metabolism. Nevertheless, the role of TGF-β3 on mitochondrial dynamics is still not well understood. Here we aimed to investigate the effect of TGF-β3 on mitochondrial dynamics of chondrocytes and reveal its underlying bio-mechanism. By using transmission electron microscopy (TEM) for the number and morphology of mitochondria, western blotting for the protein expressions, immunofluorescence for the cytoplasmic distributions of proteins, and RNA sequencing for the transcriptome changes related to mitochondrial dynamics. We found that TGF-β3 could increase the number of mitochondria in chondrocytes. TGF-β3-enhanced mitochondrial number was via promoting the mitochondrial fission. The mitochondrial fission induced by TGF-β3 was mediated by AMPK signaling. TGF-β3 activated canonical p-Smad3 signaling and resultantly mediated AMPK-induced mitochondrial fission. Taken together, these results elucidate an understanding of the role of TGF-β3 on mitochondrial dynamics in chondrocytes and provide potential cues for therapeutic strategies in cartilage injury and OA disease in terms of energy metabolism.

References

[1] Muthu S, Korpershoek JV, Novais EJ, Tawy GF, Hollander AP, Martin I. Failure of cartilage regeneration: emerging hypotheses and related therapeutic strategies. Nat Rev Rheumatol. 2023;19(7):403-416.

[2] Zhou C, Yang Y, Duan M, et al. Biomimetic fibers based on equidistant micropillar arrays determines chondrocyte fate via mechanoadaptability. Adv Healthc Mater. 2023;e2301685.

[3] Luo Y, Sinkeviciute D, He Y, et al. The minor collagens in articular cartilage. Protein Cell. 2017;8(8):560-572.

[4] Du X, Cai L, Xie J, Zhou X. The role of TGF-beta3 in cartilage development and osteoarthritis. Bone Res. 2023;11(1):2.

[5] Duan M, Xia S, Liu Y, et al. Stiffened fibre-like microenvironment based on patterned equidistant micropillars directs chondrocyte hypertrophy. Mater Today Bio. 2023;20:100682.

[6] Xie J, Zhang D, Lin Y, Yuan Q, Zhou X. Anterior cruciate ligament transection-induced cellular and extracellular events in menisci: implications for osteoarthritis. Am J Sports Med. 2018;46(5):1185-1198.

[7] Fernandez-Moreno M, Rego-Perez I, Blanco FJ. Is osteoarthritis a mitochondrial disease? What is the evidence. Curr Opin Rheumatol. 2022;34(1):46-53.

[8] Grimaud HD, Redini F. Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor Rev. 2002;13(3):241-257.

[9] Lin Y, Chen S, Liu Y, Guo F, Miao Q, Huang H. A composite hydrogel scaffold based on collagen and carboxymethyl chitosan for cartilage regeneration through one-step chemical crosslinking. Int J Biol Macromol. 2023;226:706-715.

[10] Yang Y, Wei J, Li J, Cui Y, Zhou X, Xie J. Lipid metabolism in cartilage and its diseases: a concise review of the research progress. Acta Biochim Biophys Sin. 2021;53(5):517-527.

[11] Zhang X, Pu X, Pi C, Xie J. The role of fibroblast growth factor 7 in cartilage development and diseases. Life Sci. 2023;326:121804.

[12] Lories RJ, Luyten FP. The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol. 2011;7(1):43-49.

[13] Kan S, Pi C, Zhang L, et al. FGF19 increases mitochondrial biogenesis and fusion in chondrocytes via the AMPKα-p38/MAPK pathway. Cell Commun Signal. 2023;21(1):55.

[14] Wei J, Yang Y, Guo D, et al. Osteoblasts induce glucose-derived ATP perturbations in chondrocytes through noncontact communication. Acta Biochim Biophys Sin. 2022;54(5):625-636.

[15] He Y, Wu Z, Xu L, et al. The role of SIRT3-mediated mitochondrial homeostasis in osteoarthritis. Cell Mol Life Sci. 2020;77(19):3729-3743.

[16] D'Amico D, Olmer M, Fouassier AM, et al. Urolithin a improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis. Aging Cell. 2022;21(8):e13662.

[17] Zhao M, Song X, Chen H, et al. Melatonin prevents chondrocyte matrix degradation in rats with experimentally induced osteoarthritis by inhibiting nuclear factor-κB via SIRT1. Nutrients. 2022;14(19):3966.

[18] Kan S, Duan M, Liu Y, Wang C, Xie J. Role of mitochondria in physiology of chondrocytes and diseases of osteoarthritis and rheumatoid arthritis. Cartilage. 2021;13(2_suppl):1102S-1121S.

[19] Zhou H, Ren J, Toan S, Mui D. Role of mitochondrial quality surveillance in myocardial infarction: from bench to bedside. Ageing Res Rev. 2021;66:101250.

[20] Li J, Chen H, Cai L, et al. SDF-1α promotes chondrocyte autophagy through CXCR4/mTOR signaling axis. Int J Mol Sci. 2023;24(2):1710.

[21] Blanco FJ, Valdes AM, Rego-Pérez I. Mitochondrial DNA variation and the pathogenesis of osteoarthritis phenotypes. Nat Rev Rheumatol. 2018;14(6):327-340.

[22] Sun D, Wang J, Toan S, et al. Molecular mechanisms of coronary microvascular endothelial dysfunction in diabetes mellitus: focus on mitochondrial quality surveillance. Angiogenesis. 2022;25(3):307-329.

[23] Yan Y, Li M, Lin J, et al. Adenosine monophosphate activated protein kinase contributes to skeletal muscle health through the control of mitochondrial function. Front Pharmacol. 2022;13:947387.

[24] Liu Y, Duan M, Zhang D, Xie J. The role of mechano growth factor in chondrocytes and cartilage defects: a concise review. Acta Biochim Biophys Sin. 2023;55(5):701-712.

[25] Chen H, Cui Y, Zhang D, Xie J, Zhou X. The role of fibroblast growth factor 8 in cartilage development and disease. J Cell Mol Med. 2022;26(4):990-999.

[26] Sengle G, Ono RN, Sasaki T, Sakai LY. Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability. J Biol Chem. 2011;286(7):5087-5099.

[27] Bush JR, Beier F. TGF-beta and osteoarthritis—the good and the bad. Nat Med. 2013;19(6):667-669.

[28] Turati M, Mousset A, Issa N, Turtoi A, Ronca R. TGF-β mediated drug resistance in solid cancer. Cytokine Growth Factor Rev. 2023;71-72:54-65.

[29] Hill CS. Transcriptional control by the SMADs. Cold Spring Harb Perspect Biol. 2016;8(10):a022079.

[30] Wara AK, Wang S, Wu C, et al. KLF10 deficiency in CD4(+) T cells triggers obesity, insulin resistance, and fatty liver. Cell Rep. 2020;33(13):108550.

[31] Xu Y, Jiang S, Hu Y, Zhang Q, Su W. TGF-beta3 induces lactate production in Sertoli cell through inhibiting the Notch pathway. Andrology. 2022;10(8):1644-1659.

[32] Wu F, Ye H, Lin J, et al. TGF-beta3 reduces apoptosis in ischemia-induced adipose-derived stem cells by enhancing DNA repair. Exp Ther Med. 2018;15(5):4400-4408.

[33] Zhou C, Duan M, Guo D, Du X, Zhang D, Xie J. Microenvironmental stiffness mediates cytoskeleton re-organization in chondrocytes through laminin-FAK mechanotransduction. Int J Oral Sci. 2022;14(1):15.

[34] Zhou C, Wang C, Xu K, et al. Hydrogel platform with tunable stiffness based on magnetic nanoparticles cross-linked GelMA for cartilage regeneration and its intrinsic biomechanism. Bioact Mater. 2022;25:615-628.

[35] Liu Y, Pu X, Duan M, et al. Biomimetic fibers derived from an equidistant micropillar platform dictate osteocyte fate via mechanoreception. Nano Lett. 2023;23:7950-7960.

[36] Guo D, Kan S, Zhang L, et al. IL-10 enhances cell-to-cell communication in chondrocytes via STAT3 signaling pathway. Cell Signal. 2023;105:110605.

[37] Li J, Fu X, Zhang D, et al. Co-culture with osteoblasts up-regulates glycolysis of chondrocytes through MAPK/HIF-1 pathway. Tissue Cell. 2022;78:101892.

[38] Xu J, Zhang Y, Yu Z, et al. Berberine mitigates hepatic insulin resistance by enhancing mitochondrial architecture via the SIRT1/Opa1 signalling pathway. Acta Biochim Biophys Sin. 2022;54(10):1464-1475.

[39] Chen X, Ji Y, Liu R, et al. Mitochondrial dysfunction: roles in skeletal muscle atrophy. J Transl Med. 2023;21(1):503.

[40] Hata A, Chen YG. TGF-beta signaling from receptors to smads. Cold Spring Harb Perspect Biol. 2016;8(9):a022061.

[41] Cai L, Pi C, Guo D, et al. TGF-β3 enhances cell-to-cell communication in chondrocytes via the ALK5/p-Smad3 axis. Biochem Biophys Res Commun. 2022;636(Pt 1):64-74.

[42] Xiang S, Lin Z, Makarcyzk MJ, et al. Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC-derived multipotent cells. Clin Transl Med. 2022;12(12):e1112.

[43] Zhao T, Sun R, Ma X, et al. Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating the TGF/β-Smad2/3 signaling pathway. Acta Biochim Biophys Sin. 2022;54(7):904-916.

[44] Mobasheri A, Rayman MP, Gualillo O, Sellam J, van der Kraan P, Fearon U. The role of metabolism in the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2017;13(5):302-311.

[45] Yi D, Yu H, Lu K, et al. AMPK signaling in energy control, cartilage biology, and osteoarthritis. Front Cell Dev Biol. 2021;9:696602.

[46] Hollander JM, Zeng L. The emerging role of glucose metabolism in cartilage development. Curr Osteoporos Rep. 2019;17(2):59-69.

[47] Sprenger HG, Langer T. The good and the bad of mitochondrial breakups. Trends Cell Biol. 2019;29(11):888-900.

[48] Wai T, Langer T. Mitochondrial dynamics and metabolic regulation. Trends Endocrinol Metab. 2016;27(2):105-117.

[49] Chan DC. Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet. 2012;46:265-287.

[50] van der Kraan PM, Goumans MJ, Blaney DE, Ten DP. Age-dependent alteration of TGF-beta signalling in osteoarthritis. Cell Tissue Res. 2012;347(1):257-265.

[51] Zhang J, Zhang W, Zhang T, et al. TGF-beta1 induces epithelial-to-mesenchymal transition via inhibiting mitochondrial functions in A549 cells. Free Radic Res. 2018;52(11–12):1432-1444.

[52] Smirnova E, Griparic L, Shurland DL, van der Bliek AM. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell. 2001;12(8):2245-2256.

[53] Lee JE, Westrate LM, Wu H, Page C, Voeltz GK. Multiple dynamin family members collaborate to drive mitochondrial division. Nature. 2016;540(7631):139-143.

[54] Ishihara N, Eura Y, Mihara K. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J Cell Sci. 2004;117(Pt 26):6535-6546.

[55] Wang S, Zhu H, Li R, et al. DNA-PKcs interacts with and phosphorylates Fis1 to induce mitochondrial fragmentation in tubular cells during acute kidney injury. Sci Signal. 2022;15(725):eabh1121.

[56] Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol. 2003;160(2):189-200.

[57] Srinivasan S, Guha M, Kashina A, Avadhani NG. Mitochondrial dysfunction and mitochondrial dynamics-the cancer connection. Biochim Biophys Acta Bioenerg. 2017;1858(8):602-614.

[58] Zhu H, Tan Y, Du W, et al. Phosphoglycerate mutase 5 exacerbates cardiac ischemia-reperfusion injury through disrupting mitochondrial quality control. Redox Biol. 2021;38:101777.

[59] Tan Y, Mui D, Toan S, Zhu P, Li R, Zhou H. SERCA overexpression improves mitochondrial quality control and attenuates cardiac microvascular ischemia-reperfusion injury. Mol Ther Nucleic Acids. 2020;22:696-707.

[60] Chen Y, Wu Y, Si H, Lu Y, Shen B. Mechanistic insights into AMPK-SIRT3 positive feedback loop-mediated chondrocyte mitochondrial quality control in osteoarthritis pathogenesis. Pharmacol Res. 2021;166:105497.

[61] Casalena G, Daehn I, Bottinger E. Transforming growth factor-beta, bioenergetics, and mitochondria in renal disease. Semin Nephrol. 2012;32(3):295-303.

[62] Fung TS, Chakrabarti R, Kollasser J, et al. Parallel kinase pathways stimulate Actin polymerization at depolarized mitochondria. Curr Biol. 2022;32(7):1577-1592.e8.

RIGHTS & PERMISSIONS

2023 The Authors. Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.